Prevalence, risk factors and awareness of hypertension in India: a systematic review

被引:0
作者
P Devi
M Rao
A Sigamani
A Faruqui
M Jose
R Gupta
P Kerkar
R K Jain
R Joshi
N Chidambaram
D S Rao
S Thanikachalam
S S Iyengar
K Verghese
V Mohan
P Pais
D Xavier
机构
[1] St John’s Medical College,Department of Pharmacology, Division of Clinical Trials
[2] St John's Research Institute,Division of Clinical Trials
[3] St John’s National Academy of Health Sciences,Department of Medicine
[4] St John’s Research Institute,Department of Cardiology
[5] Fortis Escorts Hospital,Department of Cardiology
[6] KEM Hospital,Department of Medicine
[7] Krishna Institute of Medical Sciences,Department of Medicine
[8] Mahatma Gandhi Institute of Medical Sciences,Department of Cardiology
[9] Rajah Muthiah Medical College,Department of Cardiology
[10] Krishna Institute of Medical Sciences,Department of Cardiology
[11] Cardiac Care Centre,Department of Medicine
[12] Sri Ramachandra University,undefined
[13] Manipal Hospital,undefined
[14] St John’s Medical College,undefined
[15] Dr Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation,undefined
[16] St John’s Medical College,undefined
[17] 14Current address: Department of Medicine,undefined
[18] Sikkim Manipal Institute of Medical Sciences,undefined
[19] Gangtok,undefined
[20] Sikkim,undefined
[21] India.,undefined
来源
Journal of Human Hypertension | 2013年 / 27卷
关键词
blood pressure; prevalence; India;
D O I
暂无
中图分类号
学科分类号
摘要
Indians have high rates of cardiovascular disease. Hypertension (HTN) is an important modifiable risk factor. There are no comprehensive reviews or a nationally representative study of the burden, treatments and outcomes of HTN in India. A systematic review was conducted to study the trends in prevalence, risk factors and awareness of HTN in India. We searched MEDLINE from January 1969 to July 2011 using prespecified medical subject heading (MeSH) terms. Of 3372 studies, 206 were included for data extraction and 174 were observational studies. Prevalence was reported in 48 studies with sample size varying from 206 to 167 331. A significant positive trend (P<0.0001) was observed over time in prevalence of HTN by region and gender. Awareness and control of HTN (11 studies) ranged from 20 to 54% and 7.5 to 25%, respectively. Increasing age, body mass index, smoking, diabetes and extra salt intake were common risk factors. In conclusion, from this systematic review, we record an increasing trend in prevalence of HTN in India by region and gender. The awareness of HTN in India is low with suboptimal control rates. There are few long-term studies to assess outcomes. Good quality long-term studies will help to understand HTN better and implement effective prevention and management programs.
引用
收藏
页码:281 / 287
页数:6
相关论文
共 149 条
[1]  
D’Agostino RB(2008)General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 743-753
[2]  
Vasan RS(1996)Blood pressure and end-stage renal disease in men N Engl J Med 334 13-18
[3]  
Pencina MJ(1989)Blood pressure as a risk factor for cardiovascular disease. The Framingham Study—30 years of follow-up Hypertension 13 I13-I18
[4]  
Wolf PA(2003)The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2560-2572
[5]  
Cobain M(2005)Global burden of hypertension: analysis of worldwide data Lancet 365 217-223
[6]  
Massaro JM(2002)Selected major risk factors and global and regional burden of disease Lancet 360 1347-1360
[7]  
Klag MJ(2005)Treatment of hypertension in chronic kidney disease Semin Nephrol 25 435-439
[8]  
Whelton PK(1989)Changes in hypertension treatment and in congestive heart failure mortality in the United States Hypertension 13 I74-I79
[9]  
Randall BL(1996)Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials J Am Coll Cardiol 27 1214-1218
[10]  
Neaton JD(2000)Reducing the global burden of blood pressure-related cardiovascular disease J Hypertens Suppl 18 S3-S6